mortality/aging
• mice die at 17 weeks of age with signs of respiratory distress
|
respiratory system
• at 17 weeks, mice exhibit pulmonary tissue stiffness
• end stage lungs exhibit fibrosis, dense lymphoid infiltration, hyperplasia of bronchus-associated lymphoid tissue and honeycombing of the peripheral lung lobules
|
• at 17 weeks
|
• mice exhibit secondary lung fibrosis that is preceded by pulmonary artery obliteration
• reconstituting mice with wild-type bone marrow or crossing mice to a Rag2 null background do not prevent fibrosis
• mice exhibit an increase in osteopontin, IL-2, IL-4, IL-6 and GM-CSF in the lungs with terminal staged lungs also expressing IL-1beta, IFN-gamma, CCL1, CCL2, CCL3, CCL4, CXCL2, CXCL10 and CXCL11
• however, lung fibrosis is not preceded by apoptosis
|
• at 17 weeks mice exhibit signs of respiratory distress such as tachypnea and hunched posture
|
cardiovascular system
• at 12 weeks, the pulmonary artery walls exhibit increased thickness compared to in wild-type mice
• obliteration of the pulmonary arteries, consisting of neointima formation induced by proliferation of vascular smooth muscle cells, coincides with perivascular inflammation
|
• mice exhibit fibrosis in the heart
|
skeleton
behavior/neurological
neoplasm
• rarely
|
integument
• mice exhibit fibrosis in the skin
|
liver/biliary system
• mice exhibit fibrosis in the periportal tracts of the liver
|
renal/urinary system
N |
• no fibrosis is observed in the kidney
|
endocrine/exocrine glands
• mice exhibit fibrosis in the thymus
|
hematopoietic system
• mice exhibit fibrosis in the thymus
|
immune system
• mice exhibit fibrosis in the thymus
|
digestive/alimentary system
• mice exhibit fibrosis in the esophagus
|
• mice exhibit fibrosis in the stomach
|
growth/size/body
• at 17 weeks
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
idiopathic pulmonary fibrosis | DOID:0050156 | J:139032 |